Semnur Pharmaceuticals SMNR
OTC SMNR
$0.30 +0.01 (+3.45%)
At close: Nov 10, 2026 · 4:00 PM EST

Semnur Pharmaceuticals (SMNR) Debt Ratio (2022 - 2026)

Updated

Semnur Pharmaceuticals' Debt Ratio was 1.08 in Q2 2026, down 56.4% from 2.49 a year earlier and down 23.7% from the prior quarter.

Analysis

Semnur Pharmaceuticals (SMNR) Debt Ratio (2022 - 2026) Analysis & Trends

For FY2025, Debt Ratio at Semnur Pharmaceuticals came in at 2.61.

  • In earlier years, Debt Ratio was 0.02 in FY2023.
  • The Q2 2026 figure marks the lowest quarterly Debt Ratio since Q1 2025.
  • Per Business Quant data, SMNR's Debt Ratio in the three quarters before Q2 2026 was 1.42 (Q1 2026), 2.61 (Q4 2025) and 5.81 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.33
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.23
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.55
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.41
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -0.06
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.56
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.51
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 Semnur Pharmaceuticals 65.31 Mn 65.10 Mn - 1.14
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.14
Jun 30, 2026 1.08
Mar 31, 2026 1.42
Dec 31, 2025 2.61
Sep 30, 2025 5.81
Jun 30, 2025 5.20
Mar 31, 2025 0.32
Dec 31, 2024 0.22
Sep 30, 2024 0.37
Jun 30, 2024 0.06
Mar 31, 2024 0.02
Dec 31, 2023 0.04
Sep 30, 2023 0.01
Jun 30, 2023 0.00
Mar 31, 2022 0.18
API Access

Semnur Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=SMNR&period=max&api_key=YOUR_API_KEY